Subscribe for free to our flagship newsletter, CDR: This Week in Retail, for news and insights from the voice of retail pharmacy.

Skip to content

Aurobindo receives FDA approval for deflazacort tablets

EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application deflazacort tablets, 6mg, 18mg, 30mg, & 36mg.

EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application deflazacort tablets, 6mg, 18mg, 30mg, & 36mg. Aurobindo Pharma’s deflazacort tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), EMFLAZA

Tablets manufactured by PTC Therapeutics Inc.

Deflazacort tablets are indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

Latest

RFK Jr. under fire at senate hearing amid CDC turmoil

RFK Jr. under fire at senate hearing amid CDC turmoil

Kennedy appeared yesterday before the Senate finance committee to testify on his Make America Healthy Again agenda after a tumultuous few weeks that ended with more than 1,000 current and former health agency employees accusing him of “putting the health of all Americans at risk”.